Aug 26, 2020 9:30am EDT Artelo Biosciences to Present at The LD 500 Virtual Investor Conference on September 1st
Jul 14, 2020 9:25am EDT Artelo Biosciences Reports Third Quarter Fiscal Year 2020 Financial Results and Provides Business Update
Jun 29, 2020 8:30am EDT Artelo Biosciences Expands Stony Brook Commercial License Agreement for FABP5 Platform for Development of Lead Cancer, Pain and Inflammation Compounds
Jun 03, 2020 9:30am EDT Artelo Biosciences to Participate in BIO Digital and The Investor Summit Conferences
May 12, 2020 9:30am EDT Artelo Biosciences Awarded Composition of Matter Patent for Novel CBD Cocrystal
Apr 14, 2020 8:30am EDT Artelo Biosciences Reports Second Quarter Fiscal Year 2020 Financial Results and Provides Business Update
Feb 24, 2020 9:00am EST Artelo Biosciences to Present at Biocom’s 10th Annual Global Life Sciences Partnering Conference
Feb 03, 2020 8:30am EST Artelo Biosciences Announces NCI Grant of $4.2 Million to Stony Brook University to Advance FABP5 Inhibitor Cancer Program
